These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 1643716

  • 1. Multicenter technical and clinical evaluation of a fully automated enzyme immunoassay for CA 125.
    Kenemans P, Bon GG, Kessler AC, Verstraeten AA, van Kamp GJ.
    Clin Chem; 1992 Aug; 38(8 Pt 1):1466-71. PubMed ID: 1643716
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Immunoassay of CEA, CA 19-9, CA 125, and CA 15-3 on the automated systems ES 300 and ES 600: methodological evaluation from a multicentre collaborative study.
    Zucchelli GC, Pilo A, Jaworek D, Masini S, Chiesa MR.
    Eur J Clin Chem Clin Biochem; 1992 Dec; 30(12):875-9. PubMed ID: 1489864
    [Abstract] [Full Text] [Related]

  • 4. Comparison of five immunoassay procedures for the ovarian carcinoma-associated antigenic determinant CA 125 in serum.
    Yedema KA, Thomas CM, Segers MF, Doesburg WH, Kenemans P.
    Eur J Obstet Gynecol Reprod Biol; 1992 Dec 28; 47(3):245-52. PubMed ID: 1294413
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Clinical and technical evaluation of ACS BR serum assay of MUC1 gene-derived glycoprotein in breast cancer, and comparison with CA 15-3 assays.
    Bon GG, von Mensdorff-Pouilly S, Kenemans P, van Kamp GJ, Verstraeten RA, Hilgers J, Meijer S, Vermorken JB.
    Clin Chem; 1997 Apr 28; 43(4):585-93. PubMed ID: 9105258
    [Abstract] [Full Text] [Related]

  • 7. Quantification of MUC1 in breast cancer patients. A method comparison study.
    Bon GG, van Kamp GJ, Verstraeten RA, von Mensdorff-Pouilly S, Hilgers J, Kenemans P.
    Eur J Obstet Gynecol Reprod Biol; 1999 Mar 28; 83(1):67-75. PubMed ID: 10221613
    [Abstract] [Full Text] [Related]

  • 8. Clinical and technical evaluation of the ACS:OV serum assay and comparison with three other CA125-detecting assays.
    Davelaar EM, Schutter EM, von Mensdorff-Pouilly S, van Kamp GJ, Verstraeten RA, Kenemans P.
    Ann Clin Biochem; 2003 Nov 28; 40(Pt 6):663-73. PubMed ID: 14629806
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Studies of clinical usefulness of new tumor markers of ovarian cancer, CA 54/61 and CA 602--CA 602 assay reagent kit, performance its normal value and correlations with other tumor markers].
    Nozawa S, Udagawa Y, Sasaki H, Ito K, Akiya K, Terashima Y, Takamizawa H, Ohkura H, Fujimoto S, Hashimoto M.
    Gan To Kagaku Ryoho; 1992 Oct 28; 19(12):2085-93. PubMed ID: 1417016
    [Abstract] [Full Text] [Related]

  • 11. Discordant serum CA 125 values in commercial immunoassays.
    van Kamp GJ, Verstraeten AA, Kenemans P.
    Eur J Obstet Gynecol Reprod Biol; 1993 Apr 28; 49(1-2):99-103. PubMed ID: 8365530
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Multicentre evaluation of a new fully automated enzyme immunoassay for total prostate-specific antigen.
    Blijenberg BG, Kessler AC, Uhl W.
    Eur J Clin Chem Clin Biochem; 1995 Dec 28; 33(12):965-73. PubMed ID: 8845430
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [A study of preclinical and clinical usefulness of new tumor markers of ovarian carcinoma, CA 54/61 and CA 602. 1. Evaluation of the diagnostic accuracy of CA 54/61, a study of the normal range of its values and its correlation with other tumor markers].
    Nozawa S, Udagawa Y, Sasaki H, Ito K, Akiya K, Terashima Y, Takamizawa H, Ohkura H, Fujimoto S, Hasimoto M.
    Gan To Kagaku Ryoho; 1992 Jun 28; 19(6):827-35. PubMed ID: 1605661
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Sources of variability in normal CA 125 levels.
    Westhoff C, Levin B, Ladd G, O'Connor J.
    Cancer Epidemiol Biomarkers Prev; 1992 Jun 28; 1(5):357-9. PubMed ID: 1305467
    [Abstract] [Full Text] [Related]

  • 20. Detection of thyroid disorders by use of basal thyrotropin values determined with an optimized "sandwich" enzyme immunoassay.
    Bernutz C, Kewenig M, Horn K, Pickardt CR.
    Clin Chem; 1985 Feb 28; 31(2):289-92. PubMed ID: 3917877
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.